Everything You Need to Know About Isopropylphenidate (IPH, IPPH and IPPD)

Within the phenidate chemical family, isopropylphenidate—also referred to as IPH, IPPH, IPD, and IPPD—is a new and less well-known stimulant.

The possibility of using isopropylphenidate in place of methylphenidate to treat ADHD and similar conditions has been studied.
According to one research, it exhibited the same fundamental action as an NDRI, having a notably high affinity for the dopamine transporter and effects on its cellular reuptake, along with methylphenidate and ethylphenidate. However, it had very little effects on norepinephrine, which was thought to indicate that it would have a better safety and toxicity profile.

Euphoria, hunger suppression, motivation boost, and stimulation are examples of subjective effects. There is less of a euphoric “rush” and a longer duration of action, but its cognitive and physical effects are said to be comparable to those of methylphenidate. These characteristics have prompted some to argue that it would be better suited for usage as a study aid or productivity boost.

The Legal Status of Isopropylphenidate (IPH, IPPH and IPPD)

• Germany: As of November 26, 2016, isopropylphenidate is governed under the New Psychoactive Substances Act (NpSG). It is illegal to produce or import something with the intention of selling it, administer it to another individual, or engage in commerce. Although prohibited, possession carries no penalties.
• Switzerland: Verzeichnis E is the particular term for isopropylphenidate, a banned drug.
• Turkey: As of February 2016, isopropylphenidate is prohibited in Turkey.
• United Kingdom: As of May 31, 2017, isopropylphenidate is a class B substance that is prohibited from being produced, supplied, or possessed in the UK.
• Canada: In Canada, isopropylphenidate is classified as a Schedule III substance.